Scleroderma: Cyclophosphamide or Transplantation

Clinical trial NCT00114530 · COMPLETED

Trial details

NCT number: NCT00114530
Sponsor: National Institute of Allergy and Infectious Diseases (NIAID)
Status: COMPLETED
Phase: Phase 2, Phase 3
Study type: INTERVENTIONAL

Scleroderma, Systemic Sclerosis Autoimmune Disease

Start date: 2005-06-01
Primary completion: 2016-04-01
Enrollment: 75

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.